About
Marcus is the Chief Financial Officer. He has a long-standing track record in this position either as employee or freelancer in the life science industry. Over the last years, he has been supporting several biotech and MedTech companies in different maturity stages. In 2001, he started his career in the life science industry as CFO of ProCorde GmbH which merged with Trigen in 2006. He finally took over the responsibility for the whole Trigen Group as the sole member of the executive board of Trigen Holdings AG. Before joining ProCorde, Marcus worked in different industries, including financial controller in a German Chinese joint venture in the province Shandong in China. Marcus holds a degree in Business Administration from the University in Münster, Germany. Marcus was co-founder and CFO of Averitas Pharma Inc. (NJ) which was successfully sold to Gruenenthal.
Position in the VCSift Database
- • 288 investors hold the Chief Financial Officer role in VCSift. Marcus Irsfeld is one of them.
- • 845 investors are based in Munich, Bayern, Germany.
Data sourced from 410,343 investor profiles. Updated June 2026.
Investment Focus
- Location
- Munich, Germany
Contact Information
Find more investors like Marcus
Search Investors